DrugPatentWatch Database Preview

Solopak Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for SOLOPAK, and what generic and branded alternatives to SOLOPAK drugs are available?

SOLOPAK has thirty-three approved drugs.

Summary for Solopak

US Patents:	0
Tradenames:	16
Ingredients:	15
NDAs:	33

Drugs and US Patents for Solopak

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Solopak	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	087077-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Solopak	HEPARIN SODIUM	heparin sodium	INJECTABLE;INJECTION	087107-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Solopak	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	INJECTABLE;INJECTION	087310-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Solopak	HYDROXYZINE HYDROCHLORIDE	hydroxyzine hydrochloride	INJECTABLE;INJECTION	087596-001	Approved Prior to Jan 1, 1982		DISCN	No	No
Solopak	HEPARIN LOCK FLUSH	heparin sodium	INJECTABLE;INJECTION	087903-001	Apr 20, 1983		DISCN	No	No

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Solopak